Publications dans lesquelles il/elle collabore avec María Mar Fernández Gatta García (9)

2009

  1. Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokineticpharmacodynamic analysis

    Clinical Pharmacokinetics, Vol. 48, Núm. 4, pp. 273-280

1997

  1. Population pharmacokinetics of caffeine in premature neonates

    European Journal of Clinical Pharmacology, Vol. 52, Núm. 3, pp. 211-217

1996

  1. Bayesian forecasting in paediatric populations

    Clinical Pharmacokinetics

  2. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies

    Clinical Pharmacology and Therapeutics, Vol. 60, Núm. 3, pp. 332-340

  3. Influence of pharmacokinetic model on vancomycin peak concentration targets

    Therapeutic Drug Monitoring, Vol. 18, Núm. 2, pp. 145-148

1992

  1. Population pharmacokinetics of imipramine in children

    European Journal of Clinical Pharmacology, Vol. 43, Núm. 1, pp. 89-92

1991

  1. COMPARACION DE DOS SISTEMAS TDX® PARA LA DETERMINACION DE CICLOSPORINA Y METABOLITOS EN SANGRE

    Revista de la Sociedad Espanola de Quimica Clinica, Vol. 10, Núm. 2, pp. 79-82

1989

  1. Predictive techniques applied to imipramine therapeutic drug monitoring

    DICP, Annals of Pharmacotherapy, Vol. 23, Núm. 5, pp. 389-394

1988

  1. High levels of tricyclic antidepressants in conventional therapy: determinant factors

    International Journal of Clinical Pharmacology Therapy and Toxicology, Vol. 26, Núm. 10, pp. 495-499